UK markets open in 2 hours 9 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,413.79 +206.66 (+1.14%) CRUDE OIL
79.17 +0.22 (+0.28%) GOLD FUTURES
2,314.60 +5.00 (+0.22%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,486.72 +1,773.10 (+3.88%)
Shanghai Pharmaceuticals Holding Co., Ltd (2607.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
As of 11:59AM HKT. Market open.
Currency in HKD
Valuation measures4
| Market cap (intra-day) | 64.19B |
| Enterprise value | 77.09B |
| Trailing P/E | 10.07 |
| Forward P/E | 7.92 |
| PEG ratio (5-yr expected) | 1.41 |
| Price/sales (ttm) | 0.14 |
| Price/book (mrq) | 0.55 |
| Enterprise value/revenue | 0.29 |
| Enterprise value/EBITDA | 8.94 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.25 |
| 52-week change 3 | -30.95% |
| S&P500 52-week change 3 | 21.33% |
| 52-week high 3 | 16.460 |
| 52-week low 3 | 10.180 |
| 50-day moving average 3 | 11.642 |
| 200-day moving average 3 | 11.877 |
Share statistics
| Avg vol (3-month) 3 | 2.4M |
| Avg vol (10-day) 3 | 2.72M |
| Shares outstanding 5 | 919.07M |
| Implied shares outstanding 6 | 5.73B |
| Float 8 | 1.65B |
| % held by insiders 1 | 24.01% |
| % held by institutions 1 | 23.96% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.66 |
| Forward annual dividend yield 4 | 5.93% |
| Trailing annual dividend rate 3 | 0.41 |
| Trailing annual dividend yield 3 | 3.66% |
| 5-year average dividend yield 4 | 3.93 |
| Payout ratio 4 | 58.80% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 18 Jul 2023 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in CNY.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 1.43% |
| Operating margin (ttm) | 3.39% |
Management effectiveness
| Return on assets (ttm) | 2.42% |
| Return on equity (ttm) | 6.27% |
Income statement
| Revenue (ttm) | 264.22B |
| Revenue per share (ttm) | 71.53 |
| Quarterly revenue growth (yoy) | 5.90% |
| Gross profit (ttm) | N/A |
| EBITDA | 9.51B |
| Net income avi to common (ttm) | 3.79B |
| Diluted EPS (ttm) | 1.110 |
| Quarterly earnings growth (yoy) | 1.60% |
Balance sheet
| Total cash (mrq) | 37.18B |
| Total cash per share (mrq) | 10.04 |
| Total debt (mrq) | 55.3B |
| Total debt/equity (mrq) | 67.36% |
| Current ratio (mrq) | 1.34 |
| Book value per share (mrq) | 18.92 |
Cash flow statement
| Operating cash flow (ttm) | 2.38B |
| Levered free cash flow (ttm) | -3.5B |
© 2024 Yahoo. All rights reserved.